Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
US-10947180-B2 · Mar 16, 2021 · US
US11420929B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11420929-B2 |
| Application number | US-202117196873-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 9, 2021 |
| Priority date | Dec 22, 2005 |
| Publication date | Aug 23, 2022 |
| Grant date | Aug 23, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Phenoxy acetic acids and phenyl propionic acids and their use in improving mitochondrial energy output in a subject are provided herein. The present compounds are activators of PPARδ and may be useful for treating conditions mediated by the same.
Opening claim text (preview).
The invention claimed is: 1. A process for the preparation of a compound of the following formula: or a pharmaceutically acceptable salt thereof, comprising saponification of a compound of formula (I): or a salt thereof, wherein: is a double bond, with either E or Z substitution; X 1 is C 1-6 alkyl substituted with morpholino; X 2 is phenylene; X 3 is phenyl substituted with one or more halogens; Ar is phenylene optionally substituted with methyl; Y 1 is O; Y 2 is O; Z is CH 2 ; R 1 is hydrogen; and R 2 is C 1-6 alkyl. 2. The process of claim 1 , wherein X 1 is morpholin-4-ylmethyl. 3. The process of claim 2 , wherein R 2 is methyl or ethyl. 4. The process of claim 1 , wherein the compound of formula (I) is methyl (Z)-[4-[3-(4-fluorophenyl)-3-[4-[3-(morpholin-4-yl) propynyl]phenyl]allyloxy]-2-methylphenoxy]acetate, or a salt thereof. 5. The process of claim 1 , wherein the compound of formula (I) is methyl (E)-[4-[3-(4-fluorophenyl)-3-[4-[3-(morpholin-4-yl) propynyl]phenyl]allyloxy]-2-methylphenoxy]acetate, or a salt thereof.
not condensed and containing further heterocyclic rings, e.g. timolol · CPC title
having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)} · CPC title
the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring · CPC title
not condensed and containing further heterocyclic rings, e.g. cromakalim · CPC title
having five-membered rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.